Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Biocryst Pharmaceuticals (DE:BO1)
FRANKFURT:BO1
Holding DE:BO1?
Track your performance easily
BioCryst (BO1) Ownership Overview
6.31% Insiders
17.52% Mutual Funds
34.51% Other Institutional Investors
17.03% ETFs
24.63% Public Companies and
Individual Investors
The ownership structure of BioCryst (DE:BO1) stock is a mix of institutional, retail, and individual investors. Approximately 69.06% of the company’s stock is owned by Institutional Investors, 6.31% is owned by Insiders, and 24.63% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Jun 25, 2024 | Amy E Mckee Director | xxxxxxxxxxxxx | $54352 |
| Jun 17, 2024 | Machelle Sanders Director | xxxxxxxxxxxxx | $28134 |
| Jun 14, 2024 | Theresa Heggie Director | xxxxxxxxxxxxx | $40925 |
| May 31, 2024 | Alan Levin Director | xxxxxxxxxxxxx | $49996 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Sep 30, 2024 | xxxxxxxxxxxxx | $295586 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $408598 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $25369271 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 15,713,637 | Institution | 7.59% | 115,872,359 | |
| 13,737,932 | Institution | 6.63% | 101,303,511 | |
| 10,584,826 | Institution | 5.11% | 78,052,507 | |
| 10,204,089 | Insider | 4.98% | 75,244,952 | |
| 8,135,804 | Institution | 3.93% | 59,993,419 | |
| 4,360,105 | Institution | 2.10% | 32,151,414 | |
| 4,289,438 | Institution | 2.07% | 31,630,316 | |
| 3,338,062 | Institution | 1.61% | 24,614,869 | |
| 2,308,330 | Institution | 1.11% | 17,021,625 | |
| 2,156,580 | Institution | 1.04% | 15,902,621 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 13,737,932 | Institution | 6.63% | 101,303,511 | |
| 4,360,105 | Institution | 2.10% | 32,151,414 | |
| 2,308,330 | Institution | 1.11% | 17,021,625 | |
| 2,156,580 | Institution | 1.04% | 15,902,621 | |
| 1,975,088 | Institution | 0.95% | 14,564,299 | |
| 1,787,181 | Institution | 0.86% | 13,178,673 | |
| 1,215,893 | Institution | 0.59% | 8,965,995 | |
| 1,049,961 | Institution | 0.51% | 7,742,412 | |
| 1,049,557 | Institution | 0.51% | 7,739,433 | |
| 778,377 | Institution | 0.38% | 5,739,752 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns Biocryst Pharmaceuticals (DE:BO1)?
According to the latest TipRanks data, approximately 34.51% of the company's stock is held by institutional investors, 6.31% is held by insiders, and 24.63% is held by retail investors.
What percentage of Biocryst Pharmaceuticals (DE:BO1) stock is held by institutional investors?
According to the latest TipRanks data, approximately 34.51% of Biocryst Pharmaceuticals (DE:BO1) stock is held by institutional investors.
What percentage of Biocryst Pharmaceuticals (DE:BO1) stock is held by retail investors?
According to the latest TipRanks data, approximately 24.63% of Biocryst Pharmaceuticals (DE:BO1) stock is held by retail investors.
Who owns the most shares of Biocryst Pharmaceuticals (DE:BO1)?
Vanguard owns the most shares of Biocryst Pharmaceuticals (DE:BO1).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.